These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35688464)

  • 21. Post-Translational Peptide Splicing and T Cell Responses.
    Mishto M; Liepe J
    Trends Immunol; 2017 Dec; 38(12):904-915. PubMed ID: 28830734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An antigenic peptide produced by peptide splicing in the proteasome.
    Vigneron N; Stroobant V; Chapiro J; Ooms A; Degiovanni G; Morel S; van der Bruggen P; Boon T; Van den Eynde BJ
    Science; 2004 Apr; 304(5670):587-90. PubMed ID: 15001714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation.
    Chapiro J; Claverol S; Piette F; Ma W; Stroobant V; Guillaume B; Gairin JE; Morel S; Burlet-Schiltz O; Monsarrat B; Boon T; Van den Eynde BJ
    J Immunol; 2006 Jan; 176(2):1053-61. PubMed ID: 16393993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elucidating the catalytic subunit composition of distinct proteasome subtypes: a crosslinking approach employing bifunctional activity-based probes.
    Cornish Carmony K; Sharma LK; Lee DM; Park JE; Lee W; Kim KB
    Chembiochem; 2015 Jan; 16(2):284-92. PubMed ID: 25477005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult human liver contains intermediate-type proteasomes with different enzymatic properties.
    Gohlke S; Kloss A; Tsokos M; Textoris-Taube K; Keller C; Kloetzel PM; Dahlmann B
    Ann Hepatol; 2014; 13(4):429-38. PubMed ID: 24927614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits.
    Kessler BM; Tortorella D; Altun M; Kisselev AF; Fiebiger E; Hekking BG; Ploegh HL; Overkleeft HS
    Chem Biol; 2001 Sep; 8(9):913-29. PubMed ID: 11564559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules.
    Berkers CR; de Jong A; Schuurman KG; Linnemann C; Meiring HD; Janssen L; Neefjes JJ; Schumacher TN; Rodenko B; Ovaa H
    J Immunol; 2015 Nov; 195(9):4085-95. PubMed ID: 26401003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell lines.
    Niewerth D; Kaspers GJ; Assaraf YG; van Meerloo J; Kirk CJ; Anderl J; Blank JL; van de Ven PM; Zweegman S; Jansen G; Cloos J
    J Hematol Oncol; 2014 Jan; 7():7. PubMed ID: 24418325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Molecular Mechanisms Governing the Assembly of the Immuno- and Thymoproteasomes in the Presence of Constitutive Proteasomes.
    Watanabe A; Yashiroda H; Ishihara S; Lo M; Murata S
    Cells; 2022 May; 11(9):. PubMed ID: 35563886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The capture proteasome assay: A method to measure proteasome activity in vitro.
    Vigneron N; Abi Habib J; Van den Eynde BJ
    Anal Biochem; 2015 Aug; 482():7-15. PubMed ID: 25912419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes.
    Burov A; Funikov S; Vagapova E; Dalina A; Rezvykh A; Shyrokova E; Lebedev T; Grigorieva E; Popenko V; Leonova O; Spasskaya D; Spirin P; Prassolov V; Karpov V; Morozov A
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermediate-type 20 S proteasomes in HeLa cells: "asymmetric" subunit composition, diversity and adaptation.
    Klare N; Seeger M; Janek K; Jungblut PR; Dahlmann B
    J Mol Biol; 2007 Oct; 373(1):1-10. PubMed ID: 17804016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The capture proteasome assay (CAPA) to evaluate subtype-specific proteasome inhibitors.
    Vigneron N; Abi Habib J; Van den Eynde BJ
    Data Brief; 2015 Sep; 4():146-51. PubMed ID: 26217779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 20S immunoproteasome and constitutive proteasome bind with the same affinity to PA28αβ and equally degrade FAT10.
    Schmidtke G; Schregle R; Alvarez G; Huber EM; Groettrup M
    Mol Immunol; 2019 Sep; 113():22-30. PubMed ID: 29208314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commentary: Are There Indeed Spliced Peptides in the Immunopeptidome?
    Mishto M
    Mol Cell Proteomics; 2021; 20():100158. PubMed ID: 34607014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide Splicing in the Proteasome Creates a Novel Type of Antigen with an Isopeptide Linkage.
    Berkers CR; de Jong A; Schuurman KG; Linnemann C; Geenevasen JA; Schumacher TN; Rodenko B; Ovaa H
    J Immunol; 2015 Nov; 195(9):4075-84. PubMed ID: 26401000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An antigen produced by splicing of noncontiguous peptides in the reverse order.
    Warren EH; Vigneron NJ; Gavin MA; Coulie PG; Stroobant V; Dalet A; Tykodi SS; Xuereb SM; Mito JK; Riddell SR; Van den Eynde BJ
    Science; 2006 Sep; 313(5792):1444-7. PubMed ID: 16960008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome.
    Mylonas R; Beer I; Iseli C; Chong C; Pak HS; Gfeller D; Coukos G; Xenarios I; Müller M; Bassani-Sternberg M
    Mol Cell Proteomics; 2018 Dec; 17(12):2347-2357. PubMed ID: 30171158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational analysis and modeling of cleavage by the immunoproteasome and the constitutive proteasome.
    Diez-Rivero CM; Lafuente EM; Reche PA
    BMC Bioinformatics; 2010 Sep; 11():479. PubMed ID: 20863374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex.
    Vigneron N; Van den Eynde BJ
    Biomolecules; 2014 Nov; 4(4):994-1025. PubMed ID: 25412285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.